ACR 26
6 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Browse all held record sources
Zoom to read. Drag to explore. Select a connection.
Every link on this map
The same connections as a table, with the reason each one is here.
| Cathleen Galgiani | Sponsors | Cathleen Galgiani sponsored ACR 26. | None |
| Astrazeneca Pharmaceuticals, LP | Lobbied on it | Astrazeneca Pharmaceuticals, LP named ACR 26 in 4 lobbying reports. | 4 reports |
| Boehringer Ingelheim Pharmaceuticals, Inc. | Lobbied on it | Boehringer Ingelheim Pharmaceuticals, Inc. named ACR 26 in 3 lobbying reports. | 3 reports |
| GSK | Lobbied on it | GSK named ACR 26 in 3 lobbying reports. | 3 reports |
| Talecris Biotherapeutics, Inc., A Wholly Owned Subsidiary of Grifols Inc. | Lobbied on it | Talecris Biotherapeutics, Inc., A Wholly Owned Subsidiary of Grifols Inc. named ACR 26 in 3 lobbying reports. | 3 reports |
| Relative to chronic obstructive pulmonary disease. | Source records | ACR 26 has an explicit source reference to Relative to chronic obstructive pulmonary disease.. | None |
In the news
Reporting about the selected subject. Articles are context and do not establish a connection on this map.
Loading coverage…